Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 4.69% | $88.31M | ― | ― | ― | |
| ASML Holding NV | 4.36% | $82.03M | €475.49B | 74.46% | 76 Outperform | |
| SAFRAN SA | 3.32% | $62.59M | €142.86B | 41.01% | 67 Neutral | |
| AstraZeneca | 2.96% | $55.68M | $323.92B | 30.42% | 80 Outperform | |
| Rolls-Royce Holdings | 2.81% | $52.92M | £111.64B | 136.36% | 71 Outperform | |
| TSMC | 2.55% | $47.99M | $1.57T | 86.91% | 81 Outperform | |
| Skandinaviska Enskilda Banken AB | 2.29% | $43.18M | kr393.81B | 16.04% | 71 Outperform | |
| ― | 2.23% | $41.99M | ― | ― | ― | |
| UniCredit SpA | 2.14% | $40.34M | €116.60B | 72.72% | 75 Outperform | |
| RWE AG | 1.99% | $37.50M | €39.23B | 78.22% | 69 Neutral |